I 

116TH CONGRESS 

2D SESSION H. R. 8059 

To direct the Secretary of Homeland Security to submit to Congress a 

report on the security and resilience of the United States medical supply 

chains, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

AUGUST 14, 2020 

Mr. TRONE (for himself and Mr. JOYCE of Pennsylvania) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on Homeland Security, and 

Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions 

as fall within the jurisdiction of the committee concerned 

A BILL 

To direct the Secretary of Homeland Security to submit 

to Congress a report on the security and resilience of 

the United States medical supply chains, and for other 

purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Strengthening our 

5 Health Security Through Resilient Medical Supply Chains 

6 Annual Review Act of 2020’’. 


pbinns on DSKJLVW7X2PROD with BILLS
2 

•HR 8059 IH

1 SEC. 2. REPORT ON SECURITY AND RESILIENCE OF THE 

2 UNITED STATES MEDICAL SUPPLY CHAINS. 

3 (a) IN GENERAL.—Not later than one year after the 

4 date of the enactment of this Act, and annually thereafter, 

5 the Secretary of Homeland Security shall submit to the 

6 Committee on Homeland Security of the House of Rep7 resentatives, and the Committee on Homeland Security 

8 and Government Affairs of the Senate a report on the se9 curity and resilience of the United States medical supply 

10 chains. Such a report shall contain a classified annex. The 

11 Secretary shall make publicly available (including by publi12 cation on the website of the Department of Homeland Se13 curity) the unclassified portion of the report. 

14 (b) CONTENTS.—The report submitted under sub15 section (a) shall— 

16 (1) review the United States supply chains for 

17 medical devices, supplies, and drugs and the vulner18 ability of such supply chains to a global disruption, 

19 such as an instance of bioterrorism, a natural dis20 aster, or a public health emergency; 

21 (2) assess the dependence of the United States 

22 on any medical devices, equipment, supplies, coun23 termeasures, vaccines, and drugs produced or 

24 sourced outside the United States; and 

25 (3) identify the actions the Federal government 

26 has taken during the year covered by the report— 


pbinns on DSKJLVW7X2PROD with BILLS
3 

•HR 8059 IH

1 (A) to promote the security and resilience 

2 of the United States medical supply chain; 

3 (B) to improve medical supply chain re4 dundancy; 

5 (C) to encourage the domestic production 

6 of medical devices, equipment, supplies, coun7 termeasures, vaccines, and drugs; and 

8 (D) to develop contingency plans for poten9 tial global disruptions; and 

10 (4) provide recommendations to agencies of the 

11 Federal Government, States, local, tribal, and terri12 torial governments, and the private sector on ways 

13 to strengthen the security and resilience of the 

14 United States medical supply chain. 

15 (c) CONSULTATION.—In preparing the report under 

16 subsection (a), the Secretary of Homeland Security— 

17 (1) shall consult with the heads of other rel18 evant Federal agencies; and 

19 (2) may consult with public health experts, 

20 health security experts, supply chain experts, and 

21 other individuals with relevant experience. 

Æ 


pbinns on DSKJLVW7X2PROD with BILLS